LTFS
STAB

Ladenburg Thalmann Financial Services’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$0 Hold
265
– – ﹤0.01% 5581
2019
Q3 		$0 Hold
265
– – ﹤0.01% 5530
2019
Q2 		$0 Hold
265
– – ﹤0.01% 5479
2019
Q1 		$0 Hold
265
– – ﹤0.01% 5402
2018
Q4 		$0 Buy
265
+245
+1,225% +$423 ﹤0.01% 5403
2018
Q3 		$0 Hold
20
– – ﹤0.01% 5379
2018
Q2 		$0 Hold
20
– – ﹤0.01% 5178
2018
Q1 		$0 Hold
20
– – ﹤0.01% 5246
2017
Q4 		$0 Sell
20
-3,550
-99% -$10.8K ﹤0.01% 5158
2017
Q3 		$12K Sell
3,570
-35,110
-91% -$99.4K ﹤0.01% 4006
2017
Q2 		$159K Hold
38,680
– – ﹤0.01% 2189
2017
Q1 		$55K Hold
38,680
– – ﹤0.01% 2839
2016
Q4 		$62K Sell
38,680
-163
-0.4% -$257 ﹤0.01% 2688
2016
Q3 		$76K Buy
38,843
+2,200
+6% +$4.83K ﹤0.01% 2455
2016
Q2 		$82K Sell
36,643
-2,200
-6% -$5.17K ﹤0.01% 2300
2016
Q1 		$126K Sell
38,843
-45
-0.1% -$151 ﹤0.01% 1909
2015
Q4 		$163K Hold
38,888
– – ﹤0.01% 1720
2015
Q3 		$158K Buy
38,888
+20,045
+106% +$81.5K ﹤0.01% 1651
2015
Q2 		$54K Sell
18,843
-15,450
-45% -$46.5K ﹤0.01% 2533
2015
Q1 		$116K Sell
34,293
-2,917
-8% -$12K ﹤0.01% 1980
2014
Q4 		$260K Buy
37,210
+1,150
+3% +$8.99K 0.01% 1260
2014
Q3 		$288K Hold
36,060
– – 0.01% 1035
2014
Q2 		$418K Hold
36,060
– – 0.01% 843
2014
Q1 		$507K Sell
36,060
-1,542
-4% -$25.1K 0.01% 721
2013
Q4 		$999K Hold
37,602
– – 0.03% 444
2013
Q3 		$1.29M Buy
37,602
+292
+0.8% +$9.66K 0.04% 332
2013
Q2 		$1.17M Buy
+37,310
New +$1.28M 0.04% 352

Other funds holding STAB

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ladenburg Thalmann Financial Services's STAB Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Statera Biopharma, Inc. Common Stock (STAB) position steady in Q4 2019 at 265 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5581.

Ladenburg Thalmann Financial Services first reported a position in STAB in Q2 2013 and has held it in 27 quarters since. The position peaked at $1.29M in Q3 2013. 14 funds tracked by Wall St. Rank hold STAB as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 265 shares of Statera Biopharma, Inc. Common Stock worth $0 as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its Statera Biopharma, Inc. Common Stock share count unchanged in Q4 2019.
  • Statera Biopharma, Inc. Common Stock made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5581 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Statera Biopharma, Inc. Common Stock in Q2 2013 and has held it in 27 quarters since.
  • Ladenburg Thalmann Financial Services's Statera Biopharma, Inc. Common Stock position peaked at $1.29M in Q3 2013.
  • 14 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.